Inventor
HAO XIAOLIN
US28 patents
⚠️ This page may combine multiple inventors who share the name “HAO XIAOLIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
13 patentsUS7705018B2Apr 27, 2010
Substituted quinolines and their uses in treatment of inflammatory and related conditions
AMGEN INC51 citations97
US7199119B2Apr 3, 2007
Antiinflammation agents
AMGEN INC75 citations95
US7919498B2Apr 5, 2011
Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors
AMGEN INC16 citations84
US8716290B2May 6, 2014
Heterocyclic compounds and their uses
AMGEN INC5 citations83
US7635695B2Dec 22, 2009
Antiinflammation agents
AMGEN INC10 citations82
US6846834B2Jan 25, 2005
Antiinflammation agents
AMGEN INC15 citations82
US9873701B2Jan 23, 2018
Heterocyclic compounds and their uses
AMGEN INC1 citations62
US8835432B2Sep 16, 2014
Heterocyclic compounds and their uses
AMGEN INC0 citations51
US9365522B2Jun 14, 2016
Pyrazole amide derivative
AMGEN INC2 citations47
US9873704B2Jan 23, 2018
Heterocyclic compounds and their uses
AMGEN INC0 citations41
US8022061B2Sep 20, 2011
N-aryl pyrazole compounds, compositions, and methods for their use
AMGEN INC0 citations39
US7763624B2Jul 27, 2010
Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors
AMGEN INC0 citations39
US7176314B2Feb 13, 2007
Inflammation modulators
AMGEN INC0 citations39
CHEN YI
6 patentsUS8193199B2Jun 5, 2012
Heterocyclic compounds and their uses
CHEN YI15 citations91
US8586739B2Nov 19, 2013
Heterocyclic compounds and their uses
CHEN YI13 citations83
US8901135B2Dec 2, 2014
Heterocyclic compounds and their uses
CHEN YI3 citations62
US8329910B2Dec 11, 2012
Quinolines for the treatment of PI3K-δ mediated diseases
CHEN YI3 citations62
US8183259B2May 22, 2012
Heterocyclic compounds and their uses
CHEN YI0 citations51
US8183258B2May 22, 2012
Heterocyclic compounds and their uses
CHEN YI0 citations51
NANJING ZHENGXIANG PHARMACEUTICALS CO LTD
4 patentsUS11446301B2Sep 20, 2022
Quinoline analogs as phosphatidylinositol 3-kinase inhibitors
NANJING ZHENGXIANG PHARMACEUTICALS CO LTD0 citations60
US11673889B2Jun 13, 2023
Substituted imidazo[4,5-c][1,8]naphthyridines as phosphodiesterase inhibitors
NANJING ZHENGXIANG PHARMACEUTICALS CO LTD0 citations49
US11542262B2Jan 3, 2023
Phosphatidylinositol 3-kinase inhibitors
NANJING ZHENGXIANG PHARMACEUTICALS CO LTD0 citations49
US11466029B2Oct 11, 2022
Compounds useful to treat influenza virus infections
NANJING ZHENGXIANG PHARMACEUTICALS CO LTD0 citations43